Antiphospholipid Syndrome
What is
Antiphospholipid Syndrome?
Antiphospholipid Syndrome is a disorder in which the blood clotting system
begins to form blood clots in the veins or arteries without obvious reason. The
symptoms of Antiphospholipid Syndrome include blood clots (thromboses) in leg or
arm veins and/or arteries; blood clots which travel to the lungs (pulmonary
emboli); sudden loss of vision; occasional episodes of numbness, tingling, or
weakness in the face or limbs; stroke; seizures; and recurrent miscarriages. All
of these symptoms are the result of blood clots occurring in small to medium
sized blood vessels. Most people affected with this disorder have only one or
two of any of these symptoms. They are however at risk for developing additional
symptoms if not treated appropriately or monitored by a physician knowledgeable
about the disorder.
What causes the
blood to clot too easily in Antiphospholipid Syndrome?
This is a autoimmune disorder. Antibodies are proteins produced by the body's immune system to
identify and remove foreign proteins, bacteria and viruses. In a person with antiphospholipid syndrome, antibodies are present in blood, which appear to
react with cell membranes, causing the cells to behave as if they have been
irritated or stimulated. This disturbs the normally well controlled clotting
system. For example, an antibody may interact with a platelet, causing the
platelet to release its cellular contents and form a clot. Antibodies also may
attach to cells that line blood vessels. This will cause the normally
non-reactive surface to appear reactive to passing blood and a clot will form.
In both instances, the antibodies are binding to sites on these cells normally
occupied by factors in the blood. When these factors can no longer bind to the
cells because their sites are occupied by the antibodies, the blood begins to
clot more easily.
What causes these
antibodies to be formed?
After being exposed to infections toxins and stress. Sometimes an antibody
is made against ones own body or self which can cause damage to tissues or
organs. This is termed an "autoimmune" disease. Common autoimmune disorders
include systemic lupus erythematosus (SLE), certain types of thyroid disease,
rheumatoid arthritis and vasculitis. Patients taking certain medications such as
Dilantin, Phenothiazines, or Hydralazine may develop Antiphospholipid Syndrome.
Frequently the antiphospholipid antibody will disappear once the medication has
been stopped. Antiphospholipid antibodies also may appear for a short time
during a viral infection and may disappear soon after the viral infection is
completely resolved. Most often, however, antiphospholipid antibodies are found
at the time a patient has developed a blood clot and none of the previously
mentioned causes can be found.
How is the
diagnosis of Antiphospholipid Syndrome made?
There is no one test that can make the diagnosis of antiphospholipid syndrome.
Generally, a series of blood tests that look for abnormal blood clotting and
antibodies are performed. The Lupus Anticoagulant is a test designed to look for
abnormal clotting. The name Lupus Anticoagulant is a misnomer since patients who
test positive for a lupus anticoagulant generally have a tendency to clot more
easily. The presence of two abnormal test results combined with clinical
symptoms makes the diagnosis of Antiphospholipid Syndrome.
How is
Antiphospholipid Syndrome treated?
Treatment of Antiphospholipid Syndrome is generally tailored for each patient
depending on his or her degree of symptoms. Patients who have had blood clots in
the veins or arteries will generally need to receive anti-clotting drugs such as
Coumadin or heparin. If clotting is severe, aspirin or a nonsteroidal
anti-inflammatory drug may be prescribed in addition to the Coumadin or heparin.
If the patient also has an associated autoimmune disorder, other drugs that
suppress the immune system such as prednisone or Cytoxan may be required. The
length of anticoagulation therapy is highly dependent on the severity of the
disorder and the type of blood clotting. In general, a minimum of six months of
anticoagulation therapy is needed and some patients require treatment
indefinitely.
Asprin can also help and
is used to treat the infertility associated with this disorder.
IVIG will take care of those
patients in whome the infertility does not respond to asprin.
Are there any
clinical conditions where antiphospholipid syndrome requires specialized care?
Yes, during pregnancy. Any woman with antiphospholipid syndrome considering
pregnancy is advised to seek high-risk pregnancy advice and to consult a
hematologist with knowledge in bleeding disorders prior to becoming pregnant.
Patients with a history of recurrent spontaneous abortions may be placed on
intravenous (IV) or subcutaneous heparin or oral aspirin during their pregnancy
in order to prevent miscarriage due to clotting of the placental blood vessels.
Information provided by
the UMHS Hemophilia and Coagulation Disorders Program, February 2003